"Alzheimer Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
Descriptor ID |
D000544
|
MeSH Number(s) |
C10.228.140.380.100 C10.574.945.249 F03.615.400.100
|
Concept/Terms |
Alzheimer Disease- Alzheimer Disease
- Alzheimer's Disease
- Dementia, Senile
- Senile Dementia
- Dementia, Alzheimer Type
- Alzheimer Type Dementia
- Alzheimer-Type Dementia (ATD)
- Alzheimer Type Dementia (ATD)
- Dementia, Alzheimer-Type (ATD)
- Alzheimer Type Senile Dementia
- Primary Senile Degenerative Dementia
- Dementia, Primary Senile Degenerative
- Alzheimer Sclerosis
- Sclerosis, Alzheimer
- Alzheimer Syndrome
- Alzheimer Dementia
- Alzheimer Dementias
- Dementia, Alzheimer
- Dementias, Alzheimer
- Senile Dementia, Alzheimer Type
Familial Alzheimer Disease (FAD)- Familial Alzheimer Disease (FAD)
- Alzheimer Disease, Familial (FAD)
- Alzheimer Diseases, Familial (FAD)
- Familial Alzheimer Diseases (FAD)
|
Below are MeSH descriptors whose meaning is more general than "Alzheimer Disease".
Below are MeSH descriptors whose meaning is more specific than "Alzheimer Disease".
This graph shows the total number of publications written about "Alzheimer Disease" by people in this website by year, and whether "Alzheimer Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 4 | 2 | 6 |
1995 | 5 | 0 | 5 |
1996 | 4 | 1 | 5 |
1997 | 9 | 0 | 9 |
1998 | 4 | 1 | 5 |
1999 | 11 | 0 | 11 |
2000 | 8 | 5 | 13 |
2001 | 12 | 2 | 14 |
2002 | 6 | 3 | 9 |
2003 | 12 | 8 | 20 |
2004 | 10 | 3 | 13 |
2005 | 14 | 5 | 19 |
2006 | 20 | 2 | 22 |
2007 | 13 | 2 | 15 |
2008 | 14 | 2 | 16 |
2009 | 18 | 5 | 23 |
2010 | 20 | 5 | 25 |
2011 | 28 | 6 | 34 |
2012 | 21 | 6 | 27 |
2013 | 23 | 4 | 27 |
2014 | 20 | 2 | 22 |
2015 | 12 | 7 | 19 |
2016 | 19 | 3 | 22 |
2017 | 23 | 2 | 25 |
2018 | 19 | 2 | 21 |
2019 | 18 | 1 | 19 |
2020 | 22 | 2 | 24 |
2021 | 30 | 1 | 31 |
2022 | 26 | 1 | 27 |
2023 | 24 | 3 | 27 |
2024 | 23 | 5 | 28 |
To return to the timeline,
click here.
Below are the most recent publications written about "Alzheimer Disease" by people in Profiles.
-
Alzheimer's disease risk gene CD2AP is a dose-sensitive determinant of synaptic structure and plasticity. Hum Mol Genet. 2024 10 07; 33(20):1815-1832.
-
Risk of antimuscarinic initiation with cholinesterase inhibitor use in Alzheimer's disease. Arch Gerontol Geriatr. 2025 Jan; 128:105629.
-
Delirium event and associated treatment modifications among older adults with Alzheimer's disease: An interrupted time-series analysis of Medicare data. Pharmacotherapy. 2024 Oct; 44(10):782-793.
-
Sensory Dysfunction, Microbial Infections, and Host Responses in Alzheimer's Disease. J Infect Dis. 2024 Sep 10; 230(Supplement_2):S150-S164.
-
Cognitive dispersion and its functional relevance in behavioral variant frontotemporal dementia and prodromal behavioral variant frontotemporal dementia. Neuropsychology. 2024 Oct; 38(7):637-652.
-
Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3?Tg-AD mice. Gut Microbes. 2024 Jan-Dec; 16(1):2389319.
-
Change in Depressive Symptoms and Longitudinal Regional Amyloid Accumulation in Unimpaired Older Adults. JAMA Netw Open. 2024 Aug 01; 7(8):e2427248.
-
Neural circuits expressing the serotonin 2C receptor regulate memory in mice and humans. Sci Adv. 2024 Jun 28; 10(26):eadl2675.
-
Clinical progress note: Anti-amyloid monoclonal antibodies. J Hosp Med. 2024 Oct; 19(10):934-937.
-
Complement C3aR signaling: Immune and metabolic modulation and its impact on Alzheimer's disease. Eur J Immunol. 2024 Aug; 54(8):e2350815.